Key facts
- It has raised $33.0M; the latest was Early Stage VC ($33.0M) in May 2025.
- Notable investors include Blue Valley Fund One.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for See All
- ·The full record, as it builds
Funding rounds
No funding rounds for See All are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About See All
Developer of an artificial intelligence-powered medical imaging technology designed to improve diagnostic accuracy and intraoperative visualization. The company offers advanced three-dimensional volumetric imaging capabilities that utilize deep learning algorithms to enhance image clarity and detail by emulating human visual sensitivity to green light, supports real-time analysis during surgical procedures, and provides tools for both rural clinics and major hospitals, enabling healthcare professionals to make informed decisions and improve patient outcomes visualization and data accuracy.
- Sector
- Healthcare
- HQ
- Nashua, NH, United States
- Founded
- 2024
- Employees
- 23
- Website
- seeall.ai/
- Ownership
- Privately Held (backing)
See All doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in See All shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on See All in its N-PORT filings yet. We sweep new filings monthly.